LAUREN COMPTON: Open Payments
NPI 1316701741 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $89 · 2025 $181
Food & beverage: $146Education: $35
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $63 |
| Agiliti Health, Inc. | 1 | $28 |
| Genentech USA, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $14 |
Products named: IMFINZI, Sonablate HIFU, SAPHNELO, Actemra, LUPRON DEPOT, JOURNAVX, HYQVIA, Prolastin-C Liquid.
Industry payments across MO — which companies pay providers there.
